PT287 – Josh Hardman –  Psychedelic Stocks, Data Privacy, and Drug Development episode artwork

EPISODE · Jan 25, 2022 · 1H 22M

PT287 – Josh Hardman – Psychedelic Stocks, Data Privacy, and Drug Development

from Psychedelics Today

In this episode of the podcast, Joe interviews Josh Hardman, Founder and Editor of Psilocybin Alpha; a news website and weekly newsletter covering the psychedelic space with a focus on emerging companies and drug development.  www.psychedelicstoday.com

Episode metadata supplied by the publisher feed · Published Jan 25, 2022

Embed this episode

NOW PLAYING

PT287 – Josh Hardman – Psychedelic Stocks, Data Privacy, and Drug Development

0:00 1:22:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Psychedelics Today?

This episode is 1 hour and 22 minutes long.

When was this Psychedelics Today episode published?

This episode was published on January 25, 2022.

Can I download this Psychedelics Today episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!